Mohamed Rahmani

Khalifa University of Science and Technology — AE

Biochemistry, Genetics and Molecular Biology · Life Sciences

54h-index17.1kcitations191works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(44), Acute Myeloid Leukemia Research(36), Histone Deacetylase Inhibitors Research(35), Cell death mechanisms and regulation(34), PI3K/AKT/mTOR signaling in cancer(20)

Publications187 total

Supplementary Table S2 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2025Open Access
Supplementary Table S1 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2025Open Access
Supplementary Figures S1-S14 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2025Open Access
Multifunctional Poly(Acrylic Acid)-Coated EuBiGd2O3 Nanocomposite as an Effective Contrast Agent in Spectral Photon Counting CT, MRI, and Fluorescence Imaging
International Journal of Nanomedicine·2025· 1 citedOpen Access
Renal Metastasis of Adenocarcinoma of the Colon
Case Reports in Pathology·2025Open Access
Overview of the Role of Tyrosine Protein Kinases and Their Inhibitors in Cancer Disease
Eurasian Journal of Analytical Chemistry·2025Open Access
1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer
Scientific Reports·2024· 14 citedOpen Access
Abstract LB_A05: Coadministration of AZD 4573 and gilteritinib exhibits a potent activity in FLT3 inhibitor-sensitive and -resistant AML cells
Molecular Cancer Therapeutics·2023
Interaction between mitochondria and microbiota modulating cellular metabolism in inflammatory bowel disease
Journal of Molecular Medicine·2023· 12 citedOpen Access
The 14-Kilodalton Human Growth Hormone Fragment a Potent Inhibitor of Angiogenesis and Tumor Metastasis
International Journal of Molecular Sciences·2023· 6 citedOpen Access
Data from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Table S1 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Table S2 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Table S2 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Figures S1-S14 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Figures S1-S14 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Table S1 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Data from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Figures S1-S14 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
Supplementary Table S2 from Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Steven Grant(47), Paul Dent(35), Yun Dai(13), Chunrong Yu(11), Paul B. Fisher(11), Margaret A. Park(10), David T. Curiel(9), Adly Yacoub(8), Sarah Spiegel(7), Devanand Sarkar(7), Clint Mitchell(7), Daniel H. Conrad(5), Rupesh Dash(5), Erin Reese(5), Geoffrey W. Krystal(5), Aditi Pandya Martin(5), Andrea Ferreira‐Gonzalez(5), Belal Azab(4), Igor P. Dmitriev(4), Guo Zhang(4)